Examining barriers and facilitators to implementing evidence-based genetic risk-stratified breast cancer screening in primary care

Introduction While there is strong evidence supporting family cancer history screening as a tool for risk-stratified cancer screening, challenges in implementation remain. Many efforts tend to focus solely on the high-risk pathway neglecting the entire patient population. This study aims to capture primary care providers' perspectives on implementing genetic-informed, risk-stratified mammography screening guidelines. Methods Semistructured interviews were conducted involving 14 providers and 5 practice leaders across 2 Georgia healthcare systems between November 2020 and May 2021. Interviews assessed the barriers and facilitators at patient, provider, and system levels using the Consolidated Framework for Implementation Research. Thematic analysis was conducted using MAXQDA, and Fishbone analysis was applied to summarize the results. Results Barriers and facilitators differed between high- and low-risk pathways. For high-risk pathways, barriers included limited provider knowledge and unclear referral protocols, while facilitators included established relationships between providers and genetic professionals and effective electronic health record systems. For low-risk pathways, barriers centered on provider acceptance, guideline inconsistency, and risk communication challenges. Conclusion Effective implementation of risk-stratified breast cancer screening requires tailored strategies to address pathway-specific barriers. Integrating ongoing education, clinical decision support, and workflow alignment may enhance program adoption.

Authors

Institutions

Publication Details

Journal
Frontiers in Cancer Control and Society
Published
2025-04-02
DOI
https://doi.org/10.3389/fcacs.2025.1521486
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Examining barriers and facilitators to implementing evidence-based genetic risk-stratified breast cancer screening in primary care

Theodore M. Johnson, Cam Escoffery, Susana Alfonso, Yue Guan et al.
1 links
Frontiers in Cancer Control and Society
BRCA gene mutations in cancer
article

Examining barriers and facilitators to implementing evidence-based genetic risk-stratified breast cancer screening in primary care

Theodore M. Johnson, Cam Escoffery, Susana Alfonso, Yue Guan, Haley Barge, Michele Cellai
article en

Abstract

Introduction While there is strong evidence supporting family cancer history screening as a tool for risk-stratified cancer screening, challenges in implementation remain. Many efforts tend to focus solely on the high-risk pathway neglecting the entire patient population. This study aims to capture primary care providers' perspectives on implementing genetic-informed, risk-stratified mammography screening guidelines. Methods Semistructured interviews were conducted involving 14 providers and 5 practice leaders across 2 Georgia healthcare systems between November 2020 and May 2021. Interviews assessed the barriers and facilitators at patient, provider, and system levels using the Consolidated Framework for Implementation Research. Thematic analysis was conducted using MAXQDA, and Fishbone analysis was applied to summarize the results. Results Barriers and facilitators differed between high- and low-risk pathways. For high-risk pathways, barriers included limited provider knowledge and unclear referral protocols, while facilitators included established relationships between providers and genetic professionals and effective electronic health record systems. For low-risk pathways, barriers centered on provider acceptance, guideline inconsistency, and risk communication challenges. Conclusion Effective implementation of risk-stratified breast cancer screening requires tailored strategies to address pathway-specific barriers. Integrating ongoing education, clinical decision support, and workflow alignment may enhance program adoption.

Frontiers in Cancer Control and SocietyVol. 3
Emory Healthcare (US), Emory University (US), CHI Health Good Samaritan (US), Georgia Department of Public Health (US)
Emory University, National Institutes of Health, Winship Cancer Institute, National Cancer Institute
Openalex Percentile: Top 92%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.